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Abstract
Background: Coronary artery calcification (CAC) has been proposed to be the underlying mechanism of the increased risk of
coronary heart disease with reductions in glomerular filtration rate (GFR). Since renal function diminishes with aging we
examined the association between GFR and CAC in the Rotterdam Study, a population-based study of elderly individuals.
Methods: The study was performed in 1703 subjects without a history of coronary heart disease. GFR was estimated using
the modification of diet in renal disease equation. We used analysis of covariance to test for mean differences in CAC
between GFR tertiles.
Results: The mean CAC scores in the middle and lowest GFR tertile did not significantly differ from the mean CAC score in
the highest GFR tertile (geometric mean CAC score 4.1 and 4.3 vs 4.2). In a multivariable model the mean CAC score did also
not differ between the GFR tertiles. As the interaction term between age and GFR was significant (P=0.037), we divided the
population in two age categories based on median age of 70 years. Below 70 years, the mean CAC scores did not differ
between the GFR tertiles. Above median age, mean CAC score in the lowest GFR tertile was significantly higher than the
mean CAC score in the highest tertile in a multivariable model (CAC 4.9 vs 4.5, p=0.010).
Conclusion: In this population-based study we observed that the association between CAC and GFR is modified by age. In
participants at least 70 years of age, a decrease in GFR was associated with increased CAC.
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Introduction
Patients with chronic renal insufficiency appear to have a higher
riskof coronaryheart disease (CHD), independentof cardiovascular
risk factors [1–10]. One of the possible underlying mechanisms is
that renal dysfunction leads to acceleration of coronary artery
calcification (CAC) [11,12], detectable by Computed Tomography
(CT), which is a strong and independent risk factor for CHD [13–
15]. Studies indeed showed that renal impairment is associated with
higher CAC scores in pre-dialysis and dialysis patients [12,16–19].
However, in population-based studies, in which persons
typically had mild to at most moderate renal dysfunction, the
association between impaired renal function and CAC either was
not significant or strongly attenuated after adjustment for
cardiovascular risk factors [11,20]. However, the population-
based studies thus far may have had negative results because their
study populations were relatively young while renal function is
known to diminish with advancing age [21–23]. Within the
Rotterdam Study, a large, prospective cohort study among elderly,
we investigated whether mild to moderate renal dysfunction is
related to increased amounts of coronary calcification.
Methods
Ethics statement
The Medical Ethics Committee of the Erasmus MC approved
the study, and all participants gave written informed consent.
Study population
The Rotterdam Study is a prospective, population-based study,
which started with a baseline visit between 1990 and 1993. All
inhabitants of a suburb of Rotterdam aged 55 years and over were
invited. In total 7983 men and women agreed to participate
(response 78%). The rationale and design of the Rotterdam Study
have been described elsewhere [24]. Follow-up visits took place in
1993 to 1994 and 1997 to 1999.
From 1997 onwards, participants through 85 years of age
completing the third phase of the first cohort were invited to
participate in the Rotterdam Coronary Calcification Study and to
undergo an electron-beam tomography scan. Of the 3371 eligible,
scans were obtained for 2063 subjects (response: 61%). Due to
several causes, i.e. metal clips from cardiac surgery, image
acquisition data could not be reconstructed or analysed in 50
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present study was for several reasons restricted to the asymptomatic
population, i.e. subjects without a history of CHD (defined as the
presence of myocardial infarction, coronary artery bypass grafting,
or percutaneous transluminal coronary angioplasty). The occur-
rence of myocardial infarction in the past may have led to changes
in life-style and medication use to reduce cardiovascular risk. Some
of the culprit plaques mayalsohave calcified only afterthe diagnosis
of myocardial infarction. Thus, the resulting calcium score may not
be a good reflection of what the calcium score would have been if
the participant had not undergone a coronary event. For all these
reasons, subjects with a history of CHD (n=218) were not included
in the study. The asymptomatic population consisted of 1795
subjects. We excluded 92 participants (5.1%), because we had too
little serum to determine the glomerular filtration rate (GFR).
Hence 1703 participants are included in this analysis.
Cardiovascular Risk Factors
During the third research round a trained research assistant
obtained information on smoking habits and medication use from
each subject during a home interview. Individuals were classified
as never having smoked, a past smoker, or a current smoker.
Clinical measurements were obtained during the visit to the
research centre. Height and weight were measured, and body
mass index was defined as weight in kilograms divided by the
square of height in meters. Blood pressure was calculated as the
average of 2 consecutive measurements at the right brachial artery
with a random zero sphygmomanometer and the participant in
sitting position. Hypertension was defined as a systolic blood
pressure of $140 mm Hg, diastolic blood pressure of $90 mm
Hg, and/or use of blood pressure–lowering medication for the
indication hypertension. After an overnight fast, blood samples
were obtained at the research centre. Serum total cholesterol was
determined by an automated enzymatic procedure using the
Roche CHOD-PAP reagent agent, and HDL was measured with
the Roche HDL cholesterol assay using PEG-modified enzymes
and dextran sulfate. Glucose was determined enzymatically by the
Hexokinase method. Diabetes mellitus was defined as the use of
antidiabetic medication and/or a random or postload serum
glucose level above 198.2 mg/dL (11.0 mmol/L).
Assessment of renal function
Serum creatinine was assessed by a nonkinetic alkaline picrate
(Jaffe) method [25]. Since the measure of creatinine can vary
across different laboratories, we first calibrated our creatinine
measures. For this purpose, mean creatinine values from the
Rotterdam Study, by sex-specific age groups (,60, 60–69, $70
years), were aligned with the corresponding corrected means from
the Third National Health and Nutrition Examination Survey
(NHANES III) participants [personal communication with Joe
Coresh]. The NHANES III creatinine measures were calibrated to
the Cleveland Clinic Laboratory, requiring a correction factor of
0.23 mg/dL (20.3 mmol/L) [26]. The glomerular filtration rate
(GFR) was estimated by the abbreviated modification of diet in
renal disease (MDRD) equation [27] as recommended by the
National Kidney Foundation [28]. Estimated GFR (eGFR in ml/
min/1.73 m
2) =1866[serum creatinine (in mg/dl)
–1.1546
Age
–0.20360.742 (if female)61.210 (if black)] [29].
Assessment of Coronary Artery Calcification
Coronary artery calcifications were assessed in the epicardial
coronary arteries detected on electron beam tomography scans.
Imaging was performed with a C-150 Imatron scanner (GE-
Imatron) according to a previously described imaging protocol [30].
Quantification of coronary calcifications was performed with
AccuImage software (AccuImage Diagnostics Corp), displaying all
pixels with a density .130 Hounsfield units. A calcification was
defined as a minimum of 2 adjacent pixels (area=0.52 mm
2)w i t ha
density .130 Hounsfield units. We placed a region of interest
around each high-density lesion in the epicardial coronary arteries.
The peak density in Hounsfield Units and the area in mm
2 of the
individual coronary calcifications were calculated. A calcium score
was obtained by multiplying each area of interest with a factor
indicating peak density within the individual area, as proposed by
Agatstonetal.[31].Weaddedthescoresforindividualcalcifications,
resulting in a calcium score for the entireepicardial coronary system.
Scanswereread by2readers(R.V.,B.S.),theformerofwhomwasat
the time a research physician dedicated to coronary calcium
research, the latter of whom is an experienced radiologist. Before
reading of the scans in our study was started, both readers had a
training period in which they read scans and compared calcium
scoring results informally. As is known from earlier studies, the
interobserver variability for total calcium scores is negligible, also in
caseof calciumscoringby non-radiologists[32,33].The scanreaders
were blinded to the clinical data of the participants. To conform to
the protocol outlines approved by the Medical Ethics Committee,
participants were not informed about calcification scores.
Statistical analysis
Because the distribution of calcium scores was skewed, we used
the logarithmic transformation of the calcium scores and added 1 to
all calcium scores to deal with values of zero (ln [CAC+1]). Cut-off
pointsfor tertilesofGFR were 68.7 and 80.0 mL/min/1.73 m
2.W e
used analysis of covariance (ANCOVA) to test for geometric mean
differences in CAC between GFR tertiles. We used the highest GFR
tertile as the reference group. In linear regression models we tested
for interaction between age and GFR, and between sex and GFR.
For all analyses we specified two ANCOVA models. In model 1 we
adjustedfor genderand age.In model 2,weadditionallyadjustedfor
the following cardiovascular risk factors: body mass index,
hypertension, total cholesterol, HDL cholesterol, smoking and
diabetes mellitus. A test for trend was performed with linear
regression analysis with the GFR tertiles as ordinal variable. In case
of missing values for the cardiovascular variables, values were
imputed using the Expectation Maximization method, which is an
iterative optimization method to estimate some unknown parame-
ters, given measurement data [34]. In the study population of 1703
participants, information for 1 cardiovascular risk factor was missing
for 8%, and information on $2 cardiovascular risk factors was
missing for 3%. All analyses were performed using SPSS statistical
software (version 15.0; SPSS Inc, Chicago, Ill) for Windows.
Results
Baseline characteristics of the total study population and
stratified by median GFR are shown in Table 1. The median
age of the group with the lower GFR was 72.1 compared to 68.4
years for the group with the higher GFR. The distribution of
different calcium score categories was comparable in both GFR
groups. Table 2 shows the distribution of different factors in
participants with CAC scores under and above 10.
In a linear regression model the interaction term between age
and GFR was significant (P=0.037) indicating that the relation
between GFR and CAC might be modified by age. We therefore
divided the population in two age categories based on the median
age of 69.9 years. Below 70 years cut-off points for tertiles of GFR
were 72.9 and 83.5 mL/min/1.73 m
2. In the age group of at least
70 years these cut-off points were 65.2 and 75.5 mL/min/
Relation between CAC and GFR
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2. No significant interaction was found between gender and
GFR in a linear regression model (P=0.142).
CAC scores among the GFR tertiles are shown in fig. 1. In the
total population, the geometric mean CAC score in the middle and
lowest GFR tertiles were not significantly higher compared to the
highest GFR category (adjusted for age and gender: geometric
mean CAC score 4.1 and 4.3 vs 4.2, P=0.558 and P=0.365
respectively; Test for trend P=0.367). After multivariable adjust-
ment, the geometric mean CAC score in the middle and lowest
GFR tertiles also were not significantly higher compared to the
highest GFR category (geometric mean CAC score 4.2 and 4.3 vs
4.2, P=0.996 and P=0.496 respectively; Test for trend P=0.497).
Below 70 years CAC scores among the GFR tertiles are shown
in fig. 1. The geometric mean CAC score in the middle and lowest
Table 1. Baseline characteristics.
All subjects (n=1703)
eGFR ,74 3 mL/min/1.73 m
2
(n=852)
eGFR .74 3 mL/min/1.73 m
2
(n=851)
Age (years) 69.9 (66.0–74.6) 72.1 (67.4–76.1) 68.4 (65.0–72.5)
Sex (male) 731 (42.9) 308 (36.2) 423 (49.7)
Body mass Index (kg/m
2) 27.064.0 27.364.0 26.863.9
Current smokers 268 (15.7) 103 (12.1) 165 (19.4)
Former smokers 902 (53.0) 458 (53.8) 444 (52.2)
Systolic blood pressure (mm Hg) 143.3621.0 144.0620.8 142.7621.1
Hypertension 1277 (75.0) 664 (77.9) 613 (72.0)
Total Cholesterol (mmol/l) 5.960.9 5.960.9 5.860.9
HDL Cholesterol (mmol/l) 1.460.4 1.460.4 1.460.4
Diabetes mellitus 223 (13.1) 104 (12.2) 119 (14.0)
eGFR (mL/min/1.73 m
2) 75.2614.7 64.068.3 86.3610.8
Range eGFR (mL/min/1.73 m
2) 16.9–164.5 16.9–74.3 74.3–164.5
Coronary artery calcification score 97.5 (9.3–439.4) 108.4 (11.6–446.6) 87.4 (7.7–430.1)
Coronary artery calcification score of 0 171 (10.0) 82 (9.6) 89 (10.5)
Coronary artery calcification score of 1–10 260 (15.3) 117 (13.7) 143 (16.8)
Coronary artery calcification score of 11–99 426 (25.0) 219 (25.7) 207 (24.3)
Coronary artery calcification score of 100–400 397 (23.3) 203 (23.8) 194 (22.8)
Coronary artery calcification score of .400 449 (26.4) 231 (27.1) 218 (25.6)
Note. Values are mean 6 SD or n (%), except for age and coronary artery calcification the median and interquartile range is given.
doi:10.1371/journal.pone.0016738.t001
Table 2. Distribution of different factors in participants with coronary artery calcification scores under and above 10.
Coronary artery calcification score
,10 (n=431)
Coronary artery calcification score .10
(n=1272)
Age (years) 68.665.1 71.265.6
Sex (male) 105 (24.4) 626 (49.2)
Body mass Index (kg/m
2) 26.563.5 27.264.1
Current smokers 47 (10.9) 221 (17.4)
Former smokers 195 (45.2) 707 (55.6)
Systolic blood pressure (mm Hg) 138.5620.5 144.9620.9
Hypertension 156 (36.2) 1003 (78.9)
Total Cholesterol (mmol/l) 5.961.0 5.960.9
HDL Cholesterol (mmol/l) 1.560.4 1.460.4
Diabetes mellitus 36 (8.4) 187 (14.7)
eGFR (mL/min/1.73 m
2) 75.8613.3 74.9615.2
Range eGFR (mL/min/1.73 m
2) 43.5–126.4 16.9–164.5
eGFR ,60 mL/min/1.73 m
2 41 (9.5) 171 (13.4)
eGFR 60–90 mL/min/1.73 m
2 165 (38.3) 514 (40.4)
eGFR .90 mL/min/1.73 m
2 225 (52.2) 587 (46.1)
Note. Values are mean 6 SD or n (%),
doi:10.1371/journal.pone.0016738.t002
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GFR category (adjusted for age and gender: geometric mean CAC
score 3.6 and 3.6 vs 3.9, P=0.134 and P=0.121 respectively; Test
for trend P=0.119; multivariable adjustment: geometric mean
CAC score 3.7 and 3.6 vs 3.9, P=0.265 and P=0.139
respectively; Test for trend P=0.137)
In the participants who were at least 70 years of age CAC scores
among the GFR tertiles are shown in fig. 1. Adjusted for age and
gender, the geometric mean CAC score in the lowest GFR tertile was
significantly higher compared to the geometric mean CAC score in
the highest GFR tertile (geometric mean CAC score 5.0 vs 4.5,
P=0.004. Test for trend P=0.004). After multivariable adjustment,
the lowest GFR tertile also had a significantly higher geometric mean
CAC score compared to the highest GFR tertile (geometric mean
CAC score 4.9 vs 4.5, P=0.010; Test for trend P=0.010).
In a secondaryanalysis we defined threegroupsdepending onthe
GFR: group 1 with GFR ,60 mL/min/1.73 m
2 (n=212), group 2
with GFR between 60 and 75 mL/min/1.73 m
2 (679) and group 3
with GFR .75 mL/min/1.73 m
2 (812). No significant differences
in mean CAC were found between the three groups in the total
population and in the young age group. In the old age group the
geometric mean CAC score in group 1 (n=164) was significantly
higher compared to group 3 (n=295): geometric mean CAC score
5.0 vs 4.5, P=0.006, test for trend P=0.005. After multivariable
adjustment, group 1 also had a significantly higher geometric mean
CAC score compared to group 3 (geometric mean CAC score 4.9vs
4.5, P=0.020; Test for trend P=0.013).
To get further insight in the question whether it is age per se or
thelowGFR rangethat isaccompanying olderage that accountsfor
the association with CAC, we performed an additional analysis. We
matched the GFR ranges of the tertiles in the older age group (these
cut-off points were 65.2 and 75.5 mL/min/1.73 m
2) to the younger
age groups and investigatedif we could also find a substantial higher
CAC in the lowest GFR group in the ‘‘young’’ individuals. Adjusted
for age and gender, the geometric mean CAC score of 3.8 in the
middle (n=242) and 3.3 in the lowest GFR group (n=110) were
not significantly different compared to geometric mean CAC score
of 3.8 in the highest GFR category (n=498), P=0.975 and
P=0.072 respectively. These results suggest that the found
relationship between reduced GFR and CAC in the older age
group is more likely to be due to older age.
Discussion
In this population-based study among elderly, we observed that
the association between kidney function and CAC depends on age.
Under 70 years, the median age, we did not find any significant
association of GFR with CAC. Above the median age we did find
a significant association of GFR with CAC. In this age group, the
geometric mean CAC score in the lowest GFR tertile was
Figure 1. Log transformed CAC score by GFR tertiles in the total population, subject below 70 years and subjects of at least 70
years. Medians (diamonds) and interquartile ranges are presented. ** significant difference between the GFR tertiles after multivariable adjustment
(P,0.05)
doi:10.1371/journal.pone.0016738.g001
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independent of cardiovascular risk factors.
Several epidemiological studies examined the association
between GFR and CAC. Ix et al. [35] evaluated 6749 participants
in the Multi-Ethnic Study of Atherosclerosis with a mean GFR of
79 ml/min per 1.73 m
2 and a mean age of 63 years. In this study
kidney function was associated with CAC (relative risk for the
prevalence of CAC was 1.41 [95% confidence interval 1.32 to
1.49] for GFR below compared with above 60 m/min per
1.73 m
2). However, this association was lost after adjustment for
age, gender, race, hypertension, and the inflammatory marker IL-
6 (relative risk for the prevalence of CAC was 1.03 [95%
confidence interval 0.98 to 1.08] for GFR below compared with
above 60 m/min per 1.73 m
2). Fox et al. [11] evaluated 319
participants in the Framingham Heart Study with a mean GFR of
86 ml/min per 1.73 m
2 and a mean age of 60 years. The authors
observed an association between GFR and CAC in unadjusted
analysis (spearman correlation coefficient 20.28, P,0.0001), but
the association was attenuated after multivariable adjustment for
cardiovascular risk factors (spearman correlation coefficient
20.10, P,0.08). Kramer et al. [20] evaluated 2660 participants
with a median age of 43.9 years in the Dallas Heart Study. The
authors did not observe an association between mild chronic
kidney disease (defined as presence of microalbuminuria and GFR
.60 ml/min per 1.73 m
2) and CAC (multivariable adjusted odds
ratio for CAC .400 versus CAC #10 was 0.97 [95% confidence
interval, 0.23 to 4.14] for mild chronic kidney disease compared to
no kidney disease). Seyahi et al. [36] evaluated 101 living kidney
donors with mean age of 48 years and 99 age- and sex-matched
healthy control subjects. The mean GFR was respectively 75.0 and
99.8 mL/min/1.73 m
2 and both groups were free of diabetes.
The prevalence of CAC was not significantly different between
kidney donors and controls (13.9% versus 17.2%; P=0.56).
Additionally no significant association was found between GFR
and CAC in the kidney donor group (spearman correlation
coefficient 0.51, P=0.62). The above mentioned studies are
comparable to our younger age group, both in GFR range and in
age. Our study results in the persons below the median age of 70
years are in line with these studies.
The results we found in the older age group are more difficult to
compare with previous studies, since the GFR range and age
groups hardly match. Studies that found an association of CAC
with impaired renal function, comprised relatively young persons
on dialysis or with very low GFR ranges [12,16–19]. Kramer et al.
[20] did not observe an association between mild chronic kidney
disease, but did observe an association between severe chronic
kidney disease (defined as GFR ,60 ml/min per 1.73 m
2
excluding end-stage kidney disease) and CAC (multivariable
adjusted odds ratio for CAC .400 versus CAC # 10 was 8.35
[95% confidence interval, 1.94 to 35.96] for severe chronic kidney
disease compared to no kidney disease).
This study is the first population-based study showing that the
association between kidney function and CAC depends on age.
Kidney dysfunction is associated with multiple physiological and
metabolic changes such as higher tricglycerides, lower high-density
lipoprotein levels, higher lipoprotein(a) levels, hypercalcemia, hyper-
homocysteinemia, hyperuricemia, elevated serum calcium-phospho-
rous product, evidence of increased inflammation and oxidative
stress, all of which have detrimental cardiovascular effects [37–44].
This metabolic milieu may accelerate the CAC process. As renal
functional decline slowly advances with older age, renal impairments
are probably of longer duration at higher ages and thus above
mentioned physiological and metabolic changes could have longer
stimulated the CAC process. This could (partly) explain why we did
observe an association between CAC and GFR in the old age group,
but not in the young age group, even after matching GFR ranges.
Strengths and limitations
Our study has several strengths, including the large number of
participants and standardized information on many potential
confounding factors. However, several limitations should be
considered. First, creatinine concentration and CAC were
measured only once, and thus the reliability of these measurements
could not be evaluated. Second, we had no other measures of
impaired kidney function available, such cystatin C or albumin-
uria. Cystatin C may be a better marker of chronic kidney disease
than creatinine and may be a better predictor for cardiovascular
disease [4]. Third, this study is cross-sectional which makes it
unsuitable to draw conclusions about causal inferences. Fourth, in
our study, 61% of the invited population participated. Character-
istics of the responders were highly similar to those of the
nonresponders. There were no significant differences with regard
to total and HDL cholesterol levels, hypertension and diabetes
mellitus. However, the scanned population was younger (mean age
difference, 1.7 years), consisted of relatively more men (46.3%
versus 37.8%), was more likely to have a history of smoking (70%
versus 63%), had a slightly higher body mass index (27.0 versus
26.7). The only considerable difference was found in the
percentage of men and women (8.5% more men among the study
population compared with nonresponders). Responders and
nonresponders did not show material differences in levels of
cardiovascular risk factors. Therefore, we think that other reasons
not related to cardiovascular risk may have caused the differential
response of men and women. Although we think it is unlikely that
selection bias has occurred, we cannot exclude a slight
underestimation or overestimation of the studied association.
Fifth, in general if the overall analyses show no association
between GFR and CAC, then exploration of interaction terms is
not appropriate. However, it was a prespecified hypothesis that the
association between reduced GFR and CAC might be modified by
age as GFR deceases with advanving age [21–23]. Sixth, we are
the first to have found that age modifies the relation between GFR
and CAC. Our results should be confirmed by future research.
Conclusion
In this population-based study we observed that the association
of CAC and GFR is modified by age. In persons under 70 years of
age, no association between GFR and CAC was found, while in
persons above 70 years the mean CAC in the lowest GFR tertile
was significantly higher compared to the highest GFR tertile.
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